Abstract:Objectives: Barrett's esophagus (BE) is a metaplastic lesion characterized by replacement of the normal squamous epithelium by columnar intestinal epithelium containing goblet cells. It is speculated that this process is an adaptation to protect cells from components of refluxate, such as gastric acid and bile acids. In contrast to the normal squamous epithelium, enterocytes of the distal ileum are adapted to transport bile acids from the intestinal lumen. Several bile acid transporters are utilized for effective removal of bile acids, including the apical sodium-dependent bile acid transporter (ASBT), the ileal bile acid-binding protein (IBABP), and the multidrug-resistant protein 3 (MRP3). We hypothesized that one of the possible functions of newly arising metaplastic epithelium, in the esophagus, is to transport bile acids. Our major goal was to evaluate the expression of bile acid transporters in normal squamous epithelium, BE with different grades of dysplasia, and esophageal adenocarcinoma (EAC). Methods: A total of 101 patients were included in this study. Immunohistochemistry (IHC) and reverse transcriptase (RT)-PCR were used to detect the expression of these transporters at the mRNA and protein levels. Results: Our immunohistochemical studies showed that all three bile acid transporters are expressed in BE glands, but not in squamous epithelium. ASBT was found in the apical border in BE biopsies. The highest frequency of ASBT expression was in patients with nondysplastic BE (9 of 15, 60%), and a progressive loss of ASBT was observed through the stages of dysplasia. ASBT was not detected in EAC (0 of 15). IBABP staining was observed in the cytoplasm of BE epithelial surface cells. Expression of IBABP was found in 100% of nondysplastic BE (14 of 14), in 93% of low-grade dysplasia (LGD, 15 of 16), in 73% of high-grade dysplasia (HGD, 10 of 14), and in 33% of EAC (5 of 15). MRP3 was expressed in the basolateral membrane in 93% of nondysplastic BE (13 of 14), in 60% of LGD (10 of 16), and in 86% of HGD (11 of 13). Only weak MRP3 staining was detected in EAC biopsies (5 of 15, 33%). In addition, RT-PCR studies showed increased expression of mRNA coding for ASBT (6.1x), IBABP (9.1x), and MRP3 (2.4x) in BE (N=13) compared with normal squamous epithelium (N=15). Significantly increased mRNA levels of IBABP (10.1x) and MRP3 (2.5x) were also detected in EAC (N=21) compared with normal squamous epithelium. Conclusions: We found that bile acid transporters expression is increased in BE tissue at the mRNA and protein levels and that expression of bile acid transporter proteins decreased with progression to cancer.

Strong Intra-Esophageal Reflux May Contribute to the Development of Barrett’s Adenocarcinoma and Affect the Localization

Barrett's Esophagus and Its Correlation with Gastroesophageal Reflux in Chinese.

204 ENDOSCOPIC EVIDENCE OF BILE REFLUX IS A STRONG INDEPENDENT FACTOR ASSOCIATED WITH THE PRESENCE OF BARRETT’S ESOPHAGUS

Bile Acids But Not Acidic Acids Induce Barrett'S Esophagus

Association between endoscopic evidence of bile reflux and Barrett's esophagus: A large-scale case-control study

A Systematic Review and Meta-Analysis of the Treatment for Barrett’s Esophagus

Esophageal Adenocarcinoma Arising from Barrett'S Epithelium in Taiwan

Long- vs short-segment Barrett's esophagus-derived adenocarcinoma: clinical features and outcomes of endoscopic submucosal dissection

Shifts in Serum Bile Acid Profiles Associated with Barrett's Esophagus and Stages of Progression to Esophageal Adenocarcinoma

[Barrett's Esophagus: Update on the Diagnosis and Treatment. Review]

Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy

Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis

The role of bile acids in the neoplastic progression of Barrett's esophagus - a short representative overview

Molecular biomarker identification for esophageal adenocarcinoma using endoscopic brushing and magnified endoscopy

The Relationship of Pathology and Clinical, Endoscopic Characteristics in Barrett' S Esophagus

Barrett's Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study

Marked Variability in the Endoscopic Diagnosis of Barrett'S Esophagus Using Japanese and Western Criteria

Recent insights into the biology of Barrett's esophagus

Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma

Long‐term Endoscopic Surveillance for Barrett's Esophagus in Japan: Multicenter Prospective Cohort Study

Gastroesophageal reflux and Barrett’s esophagus: a pathway to esophageal adenocarcinoma